Jennison Associates’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.4M | Sell |
839,159
-421,994
| -33% | -$39.9M | 0.05% | 159 |
|
|
2025
Q1 | $80.1M | Sell |
1,261,153
-628,389
| -33% | -$39.9M | 0.06% | 151 |
|
|
2024
Q4 | $87.8M | Buy |
1,889,542
+148,656
| +9% | +$6.9M | 0.05% | 152 |
|
|
2024
Q3 | $50.1M | Buy |
1,740,886
+612,854
| +54% | +$17.6M | 0.03% | 229 |
|
|
2024
Q2 | $16.3M | Sell |
1,128,032
-465,801
| -29% | -$6.74M | 0.01% | 345 |
|
|
2024
Q1 | $25.6M | Buy |
1,593,833
+8,448
| +0.5% | +$136K | 0.02% | 317 |
|
|
2023
Q4 | $31.5M | Buy |
1,585,385
+142,819
| +10% | +$2.84M | 0.02% | 266 |
|
|
2023
Q3 | $23.5M | Buy |
1,442,566
+53,903
| +4% | +$879K | 0.02% | 292 |
|
|
2023
Q2 | $29.4M | Buy |
1,388,663
+359,665
| +35% | +$7.6M | 0.02% | 268 |
|
|
2023
Q1 | $20.7M | Sell |
1,028,998
-1,629
| -0.2% | -$32.7K | 0.02% | 324 |
|
|
2022
Q4 | $26.9M | Buy |
+1,030,627
| New | +$26.9M | 0.03% | 281 |
|